The prevalence of human papillomavirus vaccination among racial and ethnic minority adolescents during the COVID-19 pandemic
JNCI Cancer Spectrum · 2023
DOI: 10.1093/jncics/pkad065 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI Cancer Spectrum, 2023. Verfasst von Chinenye Lynette Ejezie und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Promotion and Behavioral Sciences, UTHealth School of Public Health, Houston, TX, USA. Hauptthemen laut MEDLINE: Papillomavirus Infections, Papillomavirus Vaccines, COVID-19. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Human papillomavirus (HPV) vaccination among adolescents has steadily improved over the past several years. However, research conducted to determine whether the COVID-19 pandemic disrupted this positive trend in HPV vaccine initiation among racial and ethnic minority adolescents is limited. Therefore, this study was conducted to determine if the COVID-19 pandemic and the resulting changes in the US health-care sector affected the increasing HPV vaccine initiation among non-Hispanic Black and Hispanic adolescents aged 13-17 years.
Methods
Using a cross-sectional design to examine data from the National Immunization Survey–Teen (2019-2021), logistic regression and moderation analysis were used to model race-specific variations in HPV vaccine initiation (n = 49 031). Two-sided P values of up to .05 were considered statistically significant.
Results
Hispanic (adjusted odds ratio [AOR] = 1.35, 95% confidence interval [CI] = 1.16 to 1.57) and non-Hispanic Black (AOR = 1.29, 95% CI = 1.10 to 1.51) adolescents had higher odds of HPV vaccine initiation than did non-Hispanic White adolescents. Additionally, the odds of HPV vaccine initiation were higher in 2021 (AOR = 1.22, 95% CI = 1.08 to 1.38) than in 2019. Other variables—age, region, sex, insurance status, and poverty status—were also associated with HPV vaccine initiation.
Conclusion
These findings demonstrate that during the COVID-19 pandemic, racial and ethnic minorities had higher odds of receiving the HPV vaccine. Therefore, more research of the impact of the pandemic on HPV vaccine initiation among non-Hispanic White and racial and ethnic minority adolescents is needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Health Promotion and Behavioral Sciences, UTHealth School of Public Health, Houston, TX, USA.
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
ORCID-Profile: Chinenye Lynette Ejezie, Paula Cuccaro
Zitieren
APA
Ejezie, C. L., Savas, L. S., Durand, C., Shegog, R., & Cuccaro, P. (2023). The prevalence of human papillomavirus vaccination among racial and ethnic minority adolescents during the COVID-19 pandemic. JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkad065
Vancouver
Ejezie CL, Savas LS, Durand C, Shegog R, Cuccaro P. The prevalence of human papillomavirus vaccination among racial and ethnic minority adolescents during the COVID-19 pandemic. JNCI Cancer Spectrum. 2023. doi:10.1093/jncics/pkad065
BibTeX
@article{Ejezie2023,
author = {Ejezie, Chinenye Lynette and Savas, Lara S and Durand, Casey and Shegog, Ross and Cuccaro, Paula},
title = {The prevalence of human papillomavirus vaccination among racial and ethnic minority adolescents during the COVID-19 pandemic},
journal = {JNCI Cancer Spectrum},
year = {2023},
doi = {10.1093/jncics/pkad065}
}
EUVIMED